Further research is needed to investigate how glycemic control and antihypertensive drug therapy can affect concentrations of ET-1, MMP-2, MMP-9, and TIMPs, and what the relationship is of these molecules with the pathogenesis of hypertension in T2D. This evidence concerns the gene MMP9 and hypertensive disorder.